Optimization of PET-MRI Imaging for the Diagnosis of ENT Cancers by Wanxin Dong

Wanxin Dong, a researcher at the University of Paris-Saclay, has unlocked a major scientific breakthrough in the diagnosis of ENT cancers in 2024 by optimizing PET-MRI imaging. This advancement addresses the urgent need to improve diagnostic methods, as nearly one million new cases and over 480,000 deaths were recorded globally in 2022.

Wanxin Dong's thesis, titled "Multiparametric PET-FDG/MRI Imaging in ENT Oncology," addresses the diagnosis of cancers of the upper aerodigestive tract, particularly squamous cell carcinomas. In 2022, nearly 946,456 new cases of ENT cancers were recorded, underscoring the urgent need to improve diagnostic methods, especially in West Africa where access to care is limited.

The main innovation lies in the combined use of PET and MRI, allowing for precise information on tumor metabolism and tissue anatomy. This approach has identified issues with variability in pharmacokinetic parameters and their lack of correlation with standard uptake value, thus making the diagnosis more reliable.

The implications of this research are significant for policymakers and the field. The optimization of PET-MRI imaging could improve patient care and reduce long-term treatment costs. Investors are encouraged to support this promising research to seize the opportunities offered by the growing medical imaging market.

« « In 2022, over 482,000 deaths were associated with ENT cancers, highlighting the urgency of improving our diagnostic methods, » says Wanxin Dong. »

« « The integration of PET-MRI imaging represents a major advancement for access to accurate diagnostics, directly impacting practitioners' decisions, » emphasizes the Lektaris team. »